GeoVax Company
GeoVax Labs develops vaccines that prevent and fight HIV infections that result in AIDS.
Estimated Revenue:
Less than $1M
Funding Status:
IPO
Industry:
Viral Vectors
Investors Number:
1
Last Funding Date:
2022-01-14
Founded Date:
1988-01-01
Headquarters:
Smyrna, Georgia, United States
Total Funding:
28048841
Last Funding Type:
Post-IPO Equity
Employee Number:
11-50